必欧瀚生物技术（合肥）有限公司

Product Center

SARS-CoV-2 Antigen quantitative assay kit（ELISA）

Sample Type: Serum, Plasma

Performance index:

Detection Sensitivity: 1.0pg/mL
Linear Range: the correlation coefficient (r) is not less than 0.9900 in the concentration range of 5.75-347.25pg/mL.
Precision: CV=1.5%-11.4%

SARS-CoV-2 IgM/IgG ANTIBODY TEST KIT

Chemiluminescence Gastric Function Detection Kit

【Packing Specification】100 servings/box

【Expected Usage】This kit is suitablefor the quantitative determination of gastrin 17 (G-17), pepsinogen Ⅰ (PGⅠ) andpepsinogen Ⅱ (PGⅡ) in human serum and plasma samples in vitro.

【Storage and ValidityPeriod】The kit should berefrigerated in the dark at 2℃-8℃, and the validity period is 12 months. Do notfreeze or expose it to direct sunlight. After opening, the kit must be sealedand refrigerated at 2℃-8℃, and it should be used within 28 days.

【Applicable Instrument】Suitablefor LUMIART-Ⅱ-1 luminescence measuring instrument produced by Hefei YuntaoPhotoelectric Technology Co., Ltd.

Video Center
more
R&D
more

Medical Services

More

News Center

06-20

2020

Biohit SARS-CoV-2 Antibody Test Kit Obtained U.S. FDA Emergency Use Authorization (EUA)
On June 18th 2020, Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit (Coll...
more
06-19

2020

Biohit SARS-CoV-2 IgM/IgG Antigen Test Kit Approved By EU
On June 12th, the SARS-CoV-2 IgM/IgG Antigen Test Kit(Colloidal Gold Method) ...
more
06-19

2020

Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit Approved By EU
On March 18th, the SARS-CoV-2 IgM/IgG Antibody Test Kit(Colloidal Gold Method...
more

More

08-25

2017

BIOHIT Healthcare (Hefei) Co., Ltd. Exhibited in the 18th Anhui Laboratory Medicine Seminar in 2016
From August 22 to August 24, the 18th Anhui Labora...
more
08-01

2017

BIOHIT Healthcare (Hefei) Co., Ltd. Was Identified as the 2017 Intellectual Property Model Enterprise in Hefei
In order to further promote the construction of a national intellectual prope...
more
07-29

2017

BIOHIT Healthcare’s Products Were Included in the “2017 Anhui New Product List”
In accordance with the Interim Measures for the Identification of Anhu...
more

More

06-20

2018

“China Early Gastric Carcinoma Screening Program” International Symposium was Held Successfully
On January 31, 2015, the “China Early Gastric Carcinoma Screening Prog...
more
06-20

2018

“Launching and Exchange Meeting of Research Topics on Multi-center Application of Appropriate Technologies for Health Management” Was Held Successfully
From April 18 to April 19, 2015, the “Launching and Exchange...
more
06-20

2018

“2015 Medical Frontier Forum: Problems and Challenges of Early Diagnosis and Early Treatment of Gastric Carcinoma” Will be Held in Suzhou
From May 29 to May 30, 2015, the “2015 Medical Frontier Forum: Pr...
more

More

03-18

2020

Special Report on BIOHIT Healthcare’s Fighting Against the Epidemic

more
06-20

2018

The Media Pay Close Attention to the Early Diagnosis and Early Treatment of Gastric Carcinoma as well as the Early Gastric Carcinoma Screening Care Program
Since the launch of the National Twelfth Five-Year Plan for Science a...
more
06-20

2018

Mass Entrepreneurship and Innovation Character Column | BIOHIT Healthcare: Feng Liu - At the Forefront of Non-invasive Detection of Gastric Diseases
文章转自微信：合肥高创孵化器 Feng Liu is the g...
more

More

Contact

必欧瀚生物技术（合肥）有限公司

Customer Service Tel.：400-990-5066

Fax：+86-551-68561553
WeChat：biohit QQNumber：2908337843

Email：public@chinabiohit.com
Homepage：www.biohit.cn

Address：Innovation Industrial Park, 800 Wangjiang West Road, High-tech Zone, Hefei City, Anhui Province